This topic contains a solution. Click here to go to the answer

Author Question: Which new category developed for the DSM-5 reflects dimensional ratings of symptoms? a. course of ... (Read 66 times)

urbanoutfitters

  • Hero Member
  • *****
  • Posts: 530
Which new category developed for the DSM-5 reflects dimensional ratings of symptoms?
 
  a. course of treatment
 b. minor neurocognitive disorder
  c. risk syndromes
 d. prognosis

Question 2

One major problem with early versions of the DSM was that most DSM categories were purely descriptive. A second major problem was that ____.
 
  a. validity and reliability were problematic
 b. the criteria in each category were difficult to understand
  c. they were based on a psychological model of illness
 d. they attempted to include too much research



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dantucker

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

c

Answer to Question 2

a




urbanoutfitters

  • Member
  • Posts: 530
Reply 2 on: Jun 22, 2018
YES! Correct, THANKS for helping me on my review


cpetit11

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Gracias!

 

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

It is believed that the Incas used anesthesia. Evidence supports the theory that shamans chewed cocoa leaves and drilled holes into the heads of patients (letting evil spirits escape), spitting into the wounds they made. The mixture of cocaine, saliva, and resin numbed the site enough to allow hours of drilling.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library